Literature DB >> 16711742

Modeling the structural basis of human CCR5 chemokine receptor function: from homology model building and molecular dynamics validation to agonist and antagonist docking.

A Fano1, D W Ritchie, A Carrieri.   

Abstract

This article describes the construction and validation of a three-dimensional model of the human CCR5 receptor using a homology-based approach starting from the X-ray structure of the bovine rhodopsin receptor. The reliability of the model is assessed through molecular dynamics and docking simulations using both natural agonists and a synthetic antagonist. Some important structural and functional features of the receptor cavity and the extracellular loops are identified, in agreement with data available from site-directed mutagenesis. The results of this study help to explain the structural basis for the recognition, activation, and inhibition processes of CCR5 and may provide fresh insights for the design of HIV-1 entry blockers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16711742     DOI: 10.1021/ci050490k

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  13 in total

1.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

2.  Binding modes of CCR5-targetting HIV entry inhibitors: partial and full antagonists.

Authors:  Ting Wang; Yong Duan
Journal:  J Mol Graph Model       Date:  2007-12-17       Impact factor: 2.518

Review 3.  Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.

Authors:  Won-Tak Choi; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

4.  A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands.

Authors:  David C Swinney; Paul Beavis; Kai-Ting Chuang; Yue Zheng; Ina Lee; Peter Gee; Jerome Deval; David M Rotstein; Marianna Dioszegi; Palani Ravendran; Jun Zhang; Surya Sankuratri; Rama Kondru; Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 5.  Anti-HIV drug development through computational methods.

Authors:  Wan-Gang Gu; Xuan Zhang; Jun-Fa Yuan
Journal:  AAPS J       Date:  2014-04-24       Impact factor: 4.009

Review 6.  Structural Analysis of Chemokine Receptor-Ligand Interactions.

Authors:  Marta Arimont; Shan-Liang Sun; Rob Leurs; Martine Smit; Iwan J P de Esch; Chris de Graaf
Journal:  J Med Chem       Date:  2017-03-10       Impact factor: 7.446

7.  Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.

Authors:  Gugan Kothandan; Changdev G Gadhe; Seung Joo Cho
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

8.  GPCRs from fusarium graminearum detection, modeling and virtual screening - the search for new routes to control head blight disease.

Authors:  Emmanuel Bresso; Roberto Togawa; Kim Hammond-Kosack; Martin Urban; Bernard Maigret; Natalia Florencio Martins
Journal:  BMC Bioinformatics       Date:  2016-12-15       Impact factor: 3.169

9.  Homology modeling a fast tool for drug discovery: current perspectives.

Authors:  V K Vyas; R D Ukawala; M Ghate; C Chintha
Journal:  Indian J Pharm Sci       Date:  2012-01       Impact factor: 0.975

10.  Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5.

Authors:  Phanourios Tamamis; Christodoulos A Floudas
Journal:  Sci Rep       Date:  2014-06-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.